Please login to the form below
NICE publishes new COVID-19 management guidelines
For patients with suspected and confirmed COVID-19, as well as those without COVID-19
Wellcome asks industry for $8bn ’COVID-Zero’ fighting fund
Charity’s initiative aims to provide “full funding” for R&D
G20 must act, say former world leaders
Richer countries must be prepared to help those who will struggle to cope with the pandemic
Merck’s Keytruda closes on second FDA verdict in genetic cancer
Merck’s application is based on data from the ongoing KeyNote-158 trial
Servier agrees to buy Symphogen to swell its cancer pipeline
Takeover deal will make Danish biotech its main antibody development unit
GSK and Vir Biotech join forces for COVID-19 antibodies
Phase 2 clinical trials could start within three to five months, pending regulatory approvals
Coronavirus causes Cancer Research UK to slash funding by £44m
Charity faces the loss of 20-25% of its fundraising income
EMA backs compassionate use of Gilead’s remdesivir for COVID-19
Drug has demonstrated activity against SARS-CoV-2 in laboratory studies
FDA approves expanded use of BMS’ Reblozyl in blood disorders
Drug treats anaemia in adults with lower-risk MDS with ring sideroblasts
Adopting a creative IP approach towards biotech clusters
Why big pharma paradigm needs to change
-
A unique ecosystem How life science and healthcare clusters are driving innovation
-
Riding the wave of digital disruptionThe challenges and rewards of meeting consumer expectations
-
Incyte and Novartis join coronavirus efforts with phase 3 studyRuxolitinib helps to inhibit immune cells from attacking the body’s own immune system
-
Moderna chairman says COVID-19 vaccine could begin phase 2 trials in springPhase 1 trial was initiated in record time, after vaccine candidate fast-tracked by US government
-
Merck’s Keytruda beats chemo in first-line colorectal cancerAchieved “clinically meaningful” improvement in progression-free survival
-
OSE lung cancer vaccine clears phase 3 hurdle, but COVID-19 stalls programmeTedopi is aimed at stimulating T-lymphocytes against tumours
-
Clinical trial of Gilead’s coronavirus hopeful remdesivir begins in UKThe pair of phase 3 trials will take place across 15 clinical sites in the UK
-
UK government reveals only 2,000 key NHS staff have been tested for coronavirusHealth officials face criticism over strict production measures
-
MHRA raises concerns over fraudulent coronavirus testsAs Amazon and Boots partner on at-home testing kits
-
Ex-BMS exec jumps to Gilead to lead research group Gilead appoints Michael Quigley to lead research team
-
New hires at Crescendo, Healx and Galecto The latest movers in pharma
-
Ex-Roche CMO Sandra Horning joins Gilead’s board of directorsHorning retired from Roche last August
-
F-star hires ex-BMS immuno-oncology leader
New CMO to oversee development of lead candidate
-
Lilly appoints Maura Dickler as VP of late phase oncology developmentShe will join the pharma firm from the Memorial Sloan Kettering Cancer Center
Latest research appointments
COVID-19 Updates and Daily News
Featured jobs
-
Account Manager (PR)
-
Great Benefits
- Account Director, Medical Communications & Events
-
£50 - 65, 000 according to skills and experience benefits
- Group Director of Medical Affairs and Scientific Strategy, Medic...
-
Substantial six figure package
- Senior Medical Writer or Lead Medical Writer
-
£Competitive Salary
-
Senior External Communications Lead
-
£Competitive Salary
-
Account Manager
-
£Competitive Salary
- Brand Manager - Medium Global Pharma Company
-
£Competitive Financial Package
-
Account Director
-
£Competitive Salary
- FDA grants emergency authorisation to chloroquine for COVID-19
- Sanofi doses first patient in global Kevzara COVID-19 trial
- Moderna chairman says COVID-19 vaccine could begin phase 2 trials in spring
- China backs use of Roche’s Actemra for coronavirus
- Novartis donates malaria drug for COVID-19 clinical trials
- Germany's coronavirus infections climb but deaths remain low
- COVID-19 is redefining the value of ‘critical jobs’: An opportunity for social care?
- How to keep your weight under control during lockdown
- Brands stepping up to show solidarity during COVID-19
- Mistura Informatics Pharmacist Donates Medicines Information Software to Tackle COVID-19
- Preparing for online interviews and remote working
- Perspective: the patient edition
PMHub
bmore group
OUR PROMISE: BETTER HEALTH FROM TRIAL TO TREATMENT.We are a full service, independent network of specialist agencies under one roof....
Latest intelligence
- COVID-19 is redefining the value of ‘critical jobs’: An opportunity for social care?
- ...
- How to keep your weight under control during lockdown
- ...
- Brands stepping up to show solidarity during COVID-19
- The brands that are stepping up to show solidarity during COVID-19 will be those that are remembered long after pandemic passes....
Quick links
Infographics
